These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15297471)

  • 1. Physiological capacity of the reticuloendothelial system for the degradation of hemoglobin vesicles (artificial oxygen carriers) after massive intravenous doses by daily repeated infusions for 14 days.
    Sakai H; Masada Y; Horinouchi H; Ikeda E; Sou K; Takeoka S; Suematsu M; Takaori M; Kobayashi K; Tsuchida E
    J Pharmacol Exp Ther; 2004 Dec; 311(3):874-84. PubMed ID: 15297471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-year observation of Wistar rats after intravenous infusion of hemoglobin-vesicles (artificial oxygen carriers).
    Sakai H; Tsuchida E; Horinouchi H; Kobayashi K
    Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(1):81-91. PubMed ID: 17364473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of hemoglobin-vesicles (artificial oxygen carriers) and their influence on organ functions in a rat model.
    Sakai H; Horinouchi H; Masada Y; Takeoka S; Ikeda E; Takaori M; Kobayashi K; Tsuchida E
    Biomaterials; 2004 Aug; 25(18):4317-25. PubMed ID: 15046922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemoglobin-vesicles as oxygen carriers: influence on phagocytic activity and histopathological changes in reticuloendothelial system.
    Sakai H; Horinouchi H; Tomiyama K; Ikeda E; Takeoka S; Kobayashi K; Tsuchida E
    Am J Pathol; 2001 Sep; 159(3):1079-88. PubMed ID: 11549600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute 40 percent exchange-transfusion with hemoglobin-vesicles (HbV) suspended in recombinant human serum albumin solution: degradation of HbV and erythropoiesis in a rat spleen for 2 weeks.
    Sakai H; Horinouchi H; Yamamoto M; Ikeda E; Takeoka S; Takaori M; Tsuchida E; Kobayashi K
    Transfusion; 2006 Mar; 46(3):339-47. PubMed ID: 16533274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatically-metabolized and -excreted artificial oxygen carrier, hemoglobin vesicles, can be safely used under conditions of hepatic impairment.
    Taguchi K; Miyasato M; Ujihira H; Watanabe H; Kadowaki D; Sakai H; Tsuchida E; Horinouchi H; Kobayashi K; Maruyama T; Otagiri M
    Toxicol Appl Pharmacol; 2010 Nov; 248(3):234-41. PubMed ID: 20709091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic study of enclosed hemoglobin and outer lipid component after the administration of hemoglobin vesicles as an artificial oxygen carrier.
    Taguchi K; Urata Y; Anraku M; Maruyama T; Watanabe H; Sakai H; Horinouchi H; Kobayashi K; Tsuchida E; Kai T; Otagiri M
    Drug Metab Dispos; 2009 Jul; 37(7):1456-63. PubMed ID: 19364827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposome-encapsulated hemoglobin (hemoglobin-vesicle) is not transferred from mother to fetus at the late stage of pregnancy in the rat model.
    Kaga M; Li H; Ohta H; Taguchi K; Ogaki S; Izumi H; Inagaki M; Tsuchiya S; Okamura K; Otagiri M; Sakai H; Yaegashi N
    Life Sci; 2012 Oct; 91(11-12):420-428. PubMed ID: 22935405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluid resuscitation with artificial oxygen carriers in hemorrhaged rats: profiles of hemoglobin-vesicle degradation and hematopoiesis for 14 days.
    Sakai H; Seishi Y; Obata Y; Takeoka S; Horinouichi H; Tsuchida E; Kobayashi K
    Shock; 2009 Feb; 31(2):192-200. PubMed ID: 18520699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemoglobin vesicles, polyethylene glycol (PEG)ylated liposomes developed as a red blood cell substitute, do not induce the accelerated blood clearance phenomenon in mice.
    Taguchi K; Urata Y; Anraku M; Watanabe H; Kadowaki D; Sakai H; Horinouchi H; Kobayashi K; Tsuchida E; Maruyama T; Otagiri M
    Drug Metab Dispos; 2009 Nov; 37(11):2197-203. PubMed ID: 19679674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemoglobin-vesicles as an artificial oxygen carrier.
    Sakai H; Sou K; Tsuchida E
    Methods Enzymol; 2009; 465():363-84. PubMed ID: 19913177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemoglobin-vesicles as artificial oxygen carriers: present situation and future visions.
    Sakai H; Sou K; Horinouchi H; Kobayashi K; Tsuchida E
    J Intern Med; 2008 Jan; 263(1):4-15. PubMed ID: 18042220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemoglobin vesicles and red blood cells as carriers of carbon monoxide prior to oxygen for resuscitation after hemorrhagic shock in a rat model.
    Sakai H; Horinouchi H; Tsuchida E; Kobayashi K
    Shock; 2009 May; 31(5):507-14. PubMed ID: 18827742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated injection of high doses of hemoglobin-encapsulated liposomes (hemoglobin vesicles) induces accelerated blood clearance in a hemorrhagic shock rat model.
    Taguchi K; Iwao Y; Watanabe H; Kadowaki D; Sakai H; Kobayashi K; Horinouchi H; Maruyama T; Otagiri M
    Drug Metab Dispos; 2011 Mar; 39(3):484-9. PubMed ID: 21123166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulation kinetics and organ distribution of Hb-vesicles developed as a red blood cell substitute.
    Sou K; Klipper R; Goins B; Tsuchida E; Phillips WT
    J Pharmacol Exp Ther; 2005 Feb; 312(2):702-9. PubMed ID: 15459236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of hemoglobin vesicles, a liposomal artificial oxygen carrier, on hematological responses, complement and anaphylactic reactions in rats.
    Abe H; Azuma H; Yamaguchi M; Fujihara M; Ikeda H; Sakai H; Takeoka S; Tsuchida E
    Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(2):157-72. PubMed ID: 17453702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemoglobin-vesicles as a transfusion alternative.
    Tsuchida E; Sakai H; Horinouchi H; Kobayashi K
    Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(6):581-8. PubMed ID: 17090430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial oxygen carriers, hemoglobin vesicles and albumin-hemes, based on bioconjugate chemistry.
    Tsuchida E; Sou K; Nakagawa A; Sakai H; Komatsu T; Kobayashi K
    Bioconjug Chem; 2009 Aug; 20(8):1419-40. PubMed ID: 19206516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathological changes of rat brain after direct injection of Hb-vesicles (artificial oxygen carriers) and neurological impact in an intracerebral hemorrhage model.
    Sakai H; Okamoto M; Ikeda E; Horinouchi H; Kobayashi K; Tsuchida E
    J Biomed Mater Res A; 2009 Sep; 90(4):1107-19. PubMed ID: 18671266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rheological properties of hemoglobin vesicles (artificial oxygen carriers) suspended in a series of plasma-substitute solutions.
    Sakai H; Sato A; Takeoka S; Tsuchida E
    Langmuir; 2007 Jul; 23(15):8121-8. PubMed ID: 17567054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.